These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 8167554)

  • 1. Monoclonal antibody anti-MPO is useful in recognizing minimally differentiated acute myeloid leukaemia.
    Praxedes MK; De Oliveira LZ; Pereira Wda V; Quintana IZ; Tabak DG; De Oliveira MS
    Leuk Lymphoma; 1994 Jan; 12(3-4):233-9. PubMed ID: 8167554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of an anti-myeloperoxidase antibody in the diagnosis and classification of acute leukaemia: a comparison with light and electron microscopy cytochemistry.
    Buccheri V; Shetty V; Yoshida N; Morilla R; Matutes E; Catovsky D
    Br J Haematol; 1992 Jan; 80(1):62-8. PubMed ID: 1311196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological and ultrastructural studies in acute biphenotypic leukaemia.
    Shetty V; Chitale A; Matutes E; Buccheri V; Morilla R; Catovsky D
    J Clin Pathol; 1993 Oct; 46(10):903-7. PubMed ID: 8227405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of monoclonal anti-myeloperoxidase (MPO7) for diagnosing acute leukaemia.
    Storr J; Dolan G; Coustan-Smith E; Barnett D; Reilly JT
    J Clin Pathol; 1990 Oct; 43(10):847-9. PubMed ID: 1977771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO).
    Bennett JM; Catovsky D; Daniel MT; Flandrin G; Galton DA; Gralnick HR; Sultan C
    Br J Haematol; 1991 Jul; 78(3):325-9. PubMed ID: 1651754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of myeloperoxidase detection by flow cytometry using two different clones of monoclonal antibodies.
    Leong CF; Kalaichelvi AV; Cheong SK; Hamidah NH; Rahman J; Sivagengei K
    Malays J Pathol; 2004 Dec; 26(2):111-6. PubMed ID: 16329563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of detecting surface and cytoplasmic antigens in acute myeloid leukaemia.
    Urbano-Ispizua A; Matutes E; Villamor N; Sierra J; Pujades A; Reverter JC; Feliu E; Cervantes F; Vives-Corrons JL; Montserrat E
    Br J Haematol; 1992 Jun; 81(2):178-83. PubMed ID: 1322689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myeloid leukaemia with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-) and CD33 (-).
    Seshi B; Kashyap A; Bennett JM
    Br J Haematol; 1992 Jul; 81(3):374-7. PubMed ID: 1382546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular markers in acute myeloid leukemia diagnosis.
    Koníková E; Glasová M; Kusenda J; Babusíková O
    Neoplasma; 1998; 45(5):282-91. PubMed ID: 9921916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of myeloid or lymphoid acute leukemia by a chemiluminescence assay. Comparison with immunocytochemistry using an antimyeloperoxidase antibody.
    da Fonseca LM; Brunetti IL; Rego EM; Garcia AB; Cilento G; Falcão RP
    Acta Haematol; 1993; 90(1):19-24. PubMed ID: 8237269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells.
    Lanza F; Latorraca A; Moretti S; Castagnari B; Ferrari L; Castoldi G
    Cytometry; 1997 Jun; 30(3):134-44. PubMed ID: 9222099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of polyclonal anti-myeloperoxidase antibody in myeloid lineage determination.
    Karnik MP; Nair CN; Zingde SM; Gothoskar BP; Zachariah L; Barbhaya S; Advani SH
    Indian J Med Res; 1994 Dec; 100():272-6. PubMed ID: 7829166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of myeloperoxidase gene expression in minimally differentiated acute myelogenous leukemia (AML-M0) using in situ hybridization.
    Traweek ST; Liu J; Braziel RM; Johnson RM; Byrnes RK
    Diagn Mol Pathol; 1995 Sep; 4(3):212-9. PubMed ID: 7493141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced myeloid specificity of CD117 compared with CD13 and CD33.
    Nomdedéu JF; Mateu R; Altès A; Llorente A; Rio C; Estivill C; López O; Ubeda J; Rubiol E
    Leuk Res; 1999 Apr; 23(4):341-7. PubMed ID: 10229319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of myeloperoxidase by flow cytometry in acute leukemia.
    Nakase K; Sartor M; Bradstock
    Cytometry; 1998 Aug; 34(4):198-202. PubMed ID: 9725460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early expression of MCS2 (CD13) in the cytoplasm of blast cells from acute myeloid leukaemia.
    Pombo de Oliveira MS; Matutes E; Rani S; Morilla R; Catovsky D
    Acta Haematol; 1988; 80(2):61-4. PubMed ID: 2901804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
    Klobusicka M; Kusenda J; Babusikova O
    Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double esterase staining of the bone marrow contributes to lineage identification in a case of minimally differentiated acute myeloid leukaemia (AML M0).
    Elghetany MT
    Clin Lab Haematol; 1999 Aug; 21(4):293-5. PubMed ID: 10583335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunocytochemistry in the diagnosis of acute myeloid leukemia (M0)].
    Saito M; Kuriyama K; Nagai K; Nonaka H; Hata T; Tusima H; Tabata S; Arimura K; Souda H; Nakamura H
    Rinsho Ketsueki; 1994 Nov; 35(11):1297-304. PubMed ID: 7823396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.